Patents by Inventor Kasey C. Vickers

Kasey C. Vickers has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Treatment for conditions associated with fibrosis and collagen deposition
    Patent number: 10119139
    Abstract: Methods, compositions, devices, and kits for treating and/or reducing the risk of developing a condition associated with fibrosis and/or collagen deposition are provided. The method of treating and/or reducing the risk of developing a condition associated with fibrosis and/or collagen deposition in a subject includes administering an effective amount a miRNA-762 inhibitor to the subject, wherein the subject is identified as having a risk of developing and/or a need for treatment of the condition associated with fibrosis and/or collagen deposition. The kit includes a vial containing an miRNA-762 inhibitor and a device for use in a surgery creating a risk of fibrosis and/or collagen deposition. The composition includes a pharmaceutical composition comprising a miRNA-762 inhibitor and a second agent selected from the group consisting of: an angiotensin-converting enzyme (ACE) inhibitors, an angiotensin receptor blocker (ARB), another antihypertensive agent, a steroid, and combinations thereof.
    Type: Grant
    Filed: September 14, 2016
    Date of Patent: November 6, 2018
    Assignees: Vanderbilt University, Yale University
    Inventors: David G. Harrison, Kim Ramil Montaniel, Kasey C. Vickers, Jing Wu, Jay D. Humphrey, Matthew R. Bersi
  • TREATMENT FOR CONDITIONS ASSOCIATED WITH FIBROSIS AND COLLAGEN DEPOSITION
    Publication number: 20170073676
    Abstract: Methods, compositions, devices, and kits for treating and/or reducing the risk of developing a condition associated with fibrosis and/or collagen deposition are provided. The method of treating and/or reducing the risk of developing a condition associated with fibrosis and/or collagen deposition in a subject includes administering an effective amount a miRNA-762 inhibitor to the subject, wherein the subject is identified as having a risk of developing and/or a need for treatment of the condition associated with fibrosis and/or collagen deposition. The kit includes a vial containing an miRNA-762 inhibitor and a device for use in a surgery creating a risk of fibrosis and/or collagen deposition. The composition includes a pharmaceutical composition comprising a miRNA-762 inhibitor and a second agent selected from the group consisting of: an angiotensin-converting enzyme (ACE) inhibitors, an angiotensin receptor blocker (ARB), another antihypertensive agent, a steroid, and combinations thereof.
    Type: Application
    Filed: September 14, 2016
    Publication date: March 16, 2017
    Inventors: David G. Harrison, Kim Ramil Montaniel, Kasey C. Vickers, Jing Wu, Jay D. Humphrey, Matthew R. Bersi